CV Event Prediction, Risk Assessment in Type 2 Diabetes
The risk assessment method used in the SAVOR-53 TIMI trial provided a “practical, well-calibrated risk prediction tool.”
Investigators sought to determine whether the use of dipeptidyl peptidase-4 inhibitors is associated with the incidence of rheumatoid arthritis.
Greater adherence to an overall healthy lifestyle is associated with a substantially lower risk for cardiovascular disease.
Antidiabetic agents for the treatment of diabetes including maintenance and max doses.